<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>According to the cellularity in the first bone marrow aspirate, 541 cases of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA) diagnosed in the Peking Union Medical College Hospital were divided into two groups--hypoplastic and hyperplastic </plain></SENT>
<SENT sid="1" pm="."><plain>Comparison of the transformation, remission and long-term survival rates in the two groups showed the following results </plain></SENT>
<SENT sid="2" pm="."><plain>(1) Transformation: In the hypoplastic group, 60% of the cases maintained the original degree of proliferation, 34% was transformed to hyperplastic, 3% had repeated transformation and 3% became leukemic </plain></SENT>
<SENT sid="3" pm="."><plain>In the hyperplastic group, 44% maintained the original degree of proliferation, 44% was transformed to hypoplastic, 9.3% had repeated transformation and 2.7% became leukemic </plain></SENT>
<SENT sid="4" pm="."><plain>(2) Remission rate: The total remission rate was 15.9% in the hypoplastic and 14.6% in the hyperplastic group </plain></SENT>
<SENT sid="5" pm="."><plain>(3) Long-term survival rate: The 1-, 5- and 10-year survival rates were 70.43%, 57.66% and 51.51% in the hypoplastic group, while they were 86.7%, 71.24% and 63.34% respectively in the hyperplastic with statistical significance (P less than 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>It is emphasized that AA can not be ruled out if there is <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> in the bone marrow smear taken for the first time or in several smears taken from the same site </plain></SENT>
<SENT sid="7" pm="."><plain>Smears taken periodically from different sites are essential for correct diagnosis </plain></SENT>
</text></document>